Using the chemical KDM4 protein inhibitor QC6352 as well as KDM4A silencing by epi-editing, we corroborated the ability of inhibiting KDM4 to reduce cancer cell viability [31, 32, 73] for breast and colorectal cancers [12, 74]. Here, KDM4A is linked to cancer.